1-5 of 5
Emilie Berard, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

More Than 10% of NPM1-Mutated AML Relapses Occur after 5 Years from Complete Remission

Sarah Bertoli, MD PhD, Suzanne Tavitian, MD, Emilie Berard, MD, Noemie Gadaud, Audrey Sarry, Francoise Huguet, MD, Eric Delabesse, MD PhD, Christian Recher, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2802.
https://doi.org/10.1182/blood-2018-99-113109
Published: 2018
Journal Articles

Is Hydroxyurea Deleterious in Patients with ELN Favorable AML and WBC Inferior to 50.10 9 /L?

Sarah Bertoli, MD PhD, Suzanne Tavitian, MD, Francoise Huguet, MD, Muriel Picard, MD, Francois Vergez, DVM, PhD, Eric Delabesse, MD PhD, Audrey Sarry, Emilie Berard, MD, Christian Recher, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3903.
https://doi.org/10.1182/blood.V130.Suppl_1.3903.3903
Published: 2017
Journal Articles

Dexamethasone Reduces Incidence of Relapse and Improves Overall Survival in Hyperleucocytic Acute Myeloid Leukemia

Christian Récher, MD PhD, Sarah Bertoli, MD PhD, Muriel Picard, MD, Emilie Bérard, MD PhD, Clément Larrue, PhD, Suzanne Tavitian, MD, Francois Vergez, DVM, PhD, Edwige Yon, Jean Ruiz, MD, Eric Delabesse, PharmD, PhD, Isabelle Luquet, MD, Laetitia Linares, PhD, Martin Carroll, MD, Audrey Sarry, Françoise Huguet, MD, Jean-Emmanuel Sarry, PhD
Journal: Blood
Blood (2016) 128 (22): 1636.
https://doi.org/10.1182/blood.V128.22.1636.1636
Published: 2016
Journal Articles

Is Intermediate-Dose Cytarabine a Good Control for Patients with Relapsed or Refractory Acute Myeloid Leukemia?

Sarah Bertoli, MD PhD, Noemie Gadaud, Suzanne Tavitian, MD, Audrey Sarry, Emilie Bérard, MD PhD, Françoise Huguet, MD, Christian Recher, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3991.
https://doi.org/10.1182/blood.V128.22.3991.3991
Published: 2016
Journal Articles

Survival Improvement for Acute Myeloid Leukemia Patients Treated in Routine Practice By Intensive Chemotherapy Between 2000 and 2014

Sarah Bertoli, MD PhD, Emilie Bérard, MD PhD, Suzanne Tavitian, MD, Anne Huynh, MD, Cecile Borel, MD, Sarah Guenounou, Isabelle Luquet, MD, Eric Delabesse, PharmD, PhD, Audrey Sarry, Guy Laurent, MD PhD, Michel Attal, Françoise Huguet, MD, Christian Récher, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3996.
https://doi.org/10.1182/blood.V128.22.3996.3996
Published: 2016